Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis
In a large real-world cohort of obese patients undergoing catheter ablation for AF, GLP-1RA therapy was associated with lower risks of AF recurrence, progression to permanent AF, cardiovascular hospitalizations, and mortality.
Authors
- A. Bisson
- P Defaye
- Adrien Carabelli (ORCID: https://orcid.org/0000-0002-8534-6160)
- Peggy Jacon (ORCID: https://orcid.org/0000-0002-6831-700X)
- Sandrine Venier (ORCID: https://orcid.org/0000-0003-1129-5089)
- Rémi Benali
- Youssou Diouf (ORCID: https://orcid.org/0009-0007-7225-8130)
- Lisa Lochon
- Laurent Fauchier
Institutions
- Université de Tours (FR)
- Inserm (FR)
- Grenoble Institute of Neurosciences (FR)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- Circulation Arrhythmia and Electrophysiology
- Published
- 2025-12-25
- DOI
- https://doi.org/10.1161/circep.125.014101
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00